Abstract
The new silver(I) ionic, water soluble, compound {[Ag(CIPH)2]NO3∙0.75MeOH∙1.2H2O} (CIPAG) was obtained by reacting silver(I) nitrate with the antibiotic ciprofloxacin (CIPH). The complex was characterized by m.p., mid-FT-IR, 1H-NMR, UV–Vis spectroscopic techniques. The crystal structures of both CIPAG and the hexahydrated neutral free drug {[CIPH]∙6(H2O)} (2) were characterized by X-ray crystallography. Two neutral ligands are datively bonded to the metal ion through the piperidinic nitrogen atoms forming a cationic {[Ag(CIPH)2]+} counter part which is neutralized by a nitrate group. The antibacterial effect of CIPAG and the commercially available hydrochloric salt of the antibiotic ({[CIPH + 2 ]∙Cl−} (3)) were tested against the bacterial species Pseudomonas aeruginosa (PAO1), Staphylococcus epidermidis (St. epidermidis) and Staphylococcus aureus (St. aureus) by the mean of minimum inhibitory concentration, minimum bactericidal concentration and their inhibitory zone (IZ). The influence of CIPAG and 3 against the formation of biofilm of PAO1 or St. aureus was also evaluated by mean of biofilm elimination concentration. The IZ caused by CIPAG which has been loaded in poly-hydroxyethylmethacrylate, is determined. The genotoxicity of CIPAG and 3 is tested in vitro against normal human corneal epithelial cells (HCET cells), by the presence of micronucleus in HCET cells and in vivo by mean of Allium cepa test.
Similar content being viewed by others
Abbreviations
- 2 :
-
Neutral hexahydrated 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid
- 3 :
-
Protonated chloride ionic salt of 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid
- BEC:
-
Biofilm elimination concentration
- CIP:
-
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid
- CIPAG :
-
{[Ag(CIPH)2]NO3∙0.75MeOH∙1.2H2O}
- EGDMA:
-
Ethylene glycol dimethacrylate
- HCET:
-
Normal human corneal epithelial cells
- HEMA:
-
Hydroxyethyl methacrylate
- IZ:
-
Inhibitory zone
- MBC:
-
Minimum bactericidal concentration
- MD:
-
Molecular dynamics
- MI:
-
Mitotic Index
- MIC:
-
Minimum inhibitory concentration
- MN:
-
Micronucleus
- Mtb:
-
Mycobacterium tuberculosis
- PAO1:
-
Pseudomonas aeruginosa
- poly-HEMA:
-
Poly-hydroxyethylmethacrylate
- SRB assay:
-
Sulforhodamine B assay
- St. aureus :
-
Staphylococcus aureus
- St. epidermidis :
-
Staphylococcus epidermidis
References
Tabbara KF, El-Sheikh HF, Aabed B (2001) Extended wear contact lens related bacterial keratitis. Br J Ophthalmol 85:842–847
Stapleton F, Carnt N (2012) Contact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxis. Eye 26:185–193
Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y (2000) Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 84:327–328
Appelbaum PC, Hunter PA (2000) The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob Agents 16:5–15
Reidy JJ, Hobden JA, Hill JM, Forman K, O’Callaghan RJ (1991) The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis. Cornea 10:25–28
Islan GA, Mukherjee A, Castro R (2015) Development of biopolymer nanocomposite for silver nanoparticles and ciprofloxacin controlled release. Int J Biol Macromol 72:740–750
Silver S (2003) Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 27:341–353
Kyros L, Banti CN, Kourkoumelis N, Kubicki M, Sainis I, Hadjikakou SK (2014) Synthesis, characterization, and binding properties towards CT-DNA and lipoxygenase of mixed-ligand silver(I) complexes with 2-mercaptothiazole and its derivatives and triphenylphosphine. J Biol Inorg Chem 19:449–464
Sainis I, Banti CN, Owczarzak AM, Kyros L, Kourkoumelis N, Kubicki M, Hadjikakou SK (2016) New antibacterial, non-genotoxic materials, derived from the functionalization of the anti-thyroid drug methimazole with silver ions. J Inorg Biochem 160:114–124
Turel I, Bukovec P, Quiros M (1997) Crystal structure of ciprofloxacin hexahydrate and its characterization. Int J Pharm 152:59
Fabbiani FPA, Dittrich B (2008) Redetermination and invariom refinement of 1-cyclo-propyl-6-fluoro-4-oxo-7-(piperazin-4-ium-1-yl)-1,4-dihydroquinoline-3-carboxylate hexahydrate at 120 K. Acta Crystallogr Sect E: Struct Rep Online 64:o2354
Fabbiani FPA, Arlin J-B, Buth G, Dittrich B, Florence AJ, Herbst-Irmer R, Sowa H (2011) Intermolecular interactions, disorder and twinning in ciprofloxacin–2,2-difluoroethanol (2/3) and ciprofloxacin–water (3/14.5). Acta Crystallogr Sect C Cryst Struct Commun 67:120
Vitorino GP, Sperandeo NR, Caira MR, Mazzieri MR (1050) A supramolecular assembly formed by hetero association of ciprofloxacin and norfloxacin in the solid state: co-crystal synthesis and characterization. Cryst Growth Des 2013:13
Li X, Hu Y, Gao Y, Zhang GGZ, Henry RF (2006) A methanol hemisolvate of ciprofloxacin. Acta Crystallogr Sect E: Struct Rep Online 62:o5803
Fabbiani FPA, Dittrich B, Florence AJ, Gelbrich T, Hursthouse MB, Kuhs WF, Shankland N, Sowa H (2009) Crystal structures with a challenge: high-pressure crystallisation of ciprofloxacin sodium salts and their recovery to ambient pressure. Cryst Eng Comm 11:1396
Mahapatra S, Venugopala KN, Row TNG (1866) A device to crystallize organic solids: structure of ciprofloxacin, midazolam, and ofloxacin as targets. Cryst Growth Des 2010:10
Batsanov SS (2001) Van der Waals radii of elements, 2001, 37, 871–885. Inorg Mater 37:871–885 (translated from Neorganicheskie Materialy, Vol. 37, No. 9, 2001, pp. 1031–1046)
Anacona JR, Toledo C (2001) Synthesis and antibacterial activity of metal complexes of ciprofloxacin. Transit Metal Chem 26:228–231
Psomas G (2008) Mononuclear metal complexes with ciprofloxacin: synthesis, characterization and DNA-binding properties. J Inorg Biochem 102:1798–1811
Parshikov IA, Freeman JP, Lay JO Jr, Beger RD, Williams AJ, Sutherland JB (1999) Regioselective transformation of ciprofloxacin to N-acetylciprofloxacin by the fungus Mucor ramannianus. FEMS Microbiol Lett 177:131–135
Wiegand I, Hilpert K, Hancock REW (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3:163–175
Danguy Cavassin E, Francisco L, de Figueiredo P, Pinhata Otoch J, Martins Seckler M, Angelo de Oliveira R, Fantinelli Franco F, Spolon Marangoni V, Zucolotto V, Sara Shafferman Levin A, Figueiredo Costa S (2015) Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria. J Nanobiotechnol 13:64–80
Shungu DL, Weinberg E, Gadebusch HH (1983) Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715). Antimicrob Agents Chemother 23:256–260
Pereira MP, Kelley SO (2011) Maximizing the therapeutic window of an antimicrobial drug by imparting mitochondrial sequestration in human cells. J Am Chem Soc 133:3260–3263
Savić ND, Milivojevic DR, Glišić BĐ, Ilic-Tomic T, Veselinovic J, Pavic A, Vasiljevic B, Nikodinovic-Runic J, Djurana MI (2016) A comparative antimicrobial and toxicological study of gold(III) and silver(I) complexes with aromatic nitrogen-containing heterocycles: synergistic activity and improved selectivity index of Au(III)/Ag(I) complexes mixture. RSC Adv 6:13193–13206
Cellini L, Di Campli E, Masulli M, Di Bartolomeo S, Allocati N (1996) Inhibition of Helicobacter pylori by garlic extract (Allium sativum). FEMS Immunol Med Microbiol 13:273–277
Kostenko V, Ceri H, Martinuzzi RJ (2007) Increased tolerance of Staphylococcus aureus to vancomycin in viscous media. FEMS Immunol Med Microbiol 51:277–288
Ude Z, Romero-Canelón I, Twamley B, Fitzgerald Hughes D, Sadler PJ, Marmion CJ (2016) A novel dual-functioning ruthenium(II)–arene complex of an anti-microbial ciprofloxacin derivative-Anti-proliferative and anti-microbial activity. J Inorg Biochem 160:210–217
Motyl M, Dorso K, Barrett J, Giacobbe R (2005) Basic microbiological techniques used in antibacterial drug discovery. In: Current protocols in pharmacology unit 13A.3.1–13A.3.22. Wiley, New York
Kalinowska-Lis U, Szewczyk EM, Checinska L, Wojciechowski JM, Wolf WM, Ochocki J (2014) Synthesis, characterization, and antimicrobial activity of silver(I) and copper(II) complexes of phosphate derivatives of pyridine and benzimidazole. Chem Med Chem 9:169–176
Pal S, Yoon EJ, Park SH, Choi EC, Song JM (2010) Metallopharmaceuticals based on silver(I) and silver (II) polydiguanide complexes: activity against burn wound pathogens. J Antimicrob Chemother 65:2134–2140
Matuschek E, Brown DFJ, Kahlmeter G (2014) Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect 20:o255–o266
Lee J-H, Park J-H, Seob Cho H, Woo Joo S, Hwan Cho M, Lee J (2013) Anti-biofilm activities of quercetin and tannic acid against Staphylococcus aureus. Biofouling 29:491–499
Nishimura S, Tsurumoto T, Yonekura A, Adachi K, Shindo H (2006) Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci 11:46–50
Viganor L, Galdino ACM, Nunes APF, Santos KRN, Branquinha MH, Devereux M, Kellett A, McCann M, Santos ALS (2016) Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells. J Antimicrob Chemother 71:128–134
Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M (2000) A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 40:175–179
Preston CAK, Khoury AE, Reid G, Bruce AW, Costertone JW (1996) Pseudomonas aeruginosa biofilms are more susceptible to ciprofloxacin than to tobramycin. Int J Antimicrob Agents 7:251–256
González-Sánchez MI, Perni S, Tommasi G, Glyn Morris N, Hawkins K, López-Cabarcos E, Prokopovich P (2015) Silver nanoparticle based antibacterial methacrylate hydrogels potential for bone graft applications. Mater Sci Eng C Mater Biol Appl 50:332–340
Cook AD, Sagers RD, Pitt WG (1993) Bacterial adhesion to poly(HEMA)-based hydrogels. J Biomed Mater Res 27:119–126
Dutta D, Kumar N, Willcox MDP (2016) Antimicrobial activity of four cationic peptides immobilised to poly-hydroxyethylmethacrylate. Biofouling 32:429–438
Andrade-Vivero P, Fernandez-Gabriel E, Alvarez-Lorenzo C, Concheiro A (2007) Improving the loading and release of NSAIDs from pHEMA hydrogels by copolymerization with functionalized monomers. J Pharm Sci 96:802–813
Tsai T-H, Chen W-L, Hu F-R (2010) Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells. Eye 24:909–917
Torres-Bugarín O, Guadalupe Zavala-Cerna M, Nava A, Flores-García A, Luisa Ramos-Ibarra M (2014) Potential uses, limitations, and basic procedures of micronuclei and nuclear abnormalities in buccal cells. Dis Markers, Article ID 956835
Banti CN, Papatriantafyllopoulou C, Manoli M, Tasiopoulos AJ, Hadjikakou SK (2016) Nimesulide silver metallodrugs, containing the mitochondriotropic, triaryl derivatives of pnictogen; anticancer activity against human breast cancer cells. Inorg Chem 55:8681–8696
Li Y, Chen DH, Yan J, Chen Y, Mittelstaedt RA, Zhang Y, Biris AS, Heflich RH, Chen T (2012) Genotoxicity of silver nanoparticles evaluated using the Ames test and in vitro micronucleus assay. Mutat Res 745:4–10
Celik A, Ogenler O, Comelekoglu U (2005) The evaluation of micronucleus frequency by acridine orange fluorescent staining in peripheral blood of rats treated with lead acetate. Mutagenesis 20:411–415
Sahu SC, Roy S, Zheng J, Yourick JJ, Sprando RL (2014) Comparative genotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells evaluated by fluorescent microscopy of cytochalasin B-blocked micronucleus formation. J Appl Toxicol 34:1200–1208
Fernandes TCC, Mazzeo DEC, Marin-Morales MA (2007) Mechanism of micronuclei formation in polyploidizated cells of Allium cepa exposed to trifluralin herbicide. Pestic Biochem Physiol 88:252–259
Leme DM, Marin-Morales MA (2009) Allium cepa test in environmental monitoring: a review on its application. Mutat Res 682:71–81 (and references there in)
Urgut OS, Ozturk II, Banti CN, Kourkoumelis N, Manoli M, Tasiopoulos AJ, Hadjikakou SK (2016) Antimony(III) halide complexes with dithiocarbamate ligands derived from thiuram degradation: the effect of the molecule’s close contacts on in vitro cytotoxic activity. Mater Sci Eng C Mater Biol Appl 58:396–408
Giacomello G, Malatesta P, Quaglia G (1964) Action of thalidomide on radical meristems of Allium cepa. Nature 201:940–941
Yıldız M, Hakkı Cigerci I, Konuk M, Fidan AF, Terzi H (2009) Determination of genotoxic effects of copper sulphate and cobalt chloride in Allium cepa root cells by chromosome aberration and comet assays. Chemosphere 75:934–938
Ahmad Z, Minkowski A, Peloquin CA, Williams KN, Mdluli KE, Grosset JH, Nuermberger EL (2011) Activity of the fluoroquinolone DC-159a in the initial and continuation phases of treatment of murine tuberculosis. Antimicrob Agents Chemother 55:1781–1783
Pucci MJ, Ackerman M, Thanassi JA, Shoen CM, Cynamon MH (2010) In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates. Antimicrob Agents Chemother 54:3478–3480
Molina-Torres CA, Barba-Marines A, Valles-Guerra O, Ocampo-Candiani J, Cavazos-Rocha N, Pucci MJ, Castro-Garza J, Vera-Cabrera L (2014) Intracellular activity of tedizolid phosphate and ACH-702 versus Mycobacterium tuberculosis infected macrophages. Ann Clin Microbiol Antimicrob 13:13
Drlica K, Franco RJ (1988) Inhibitors of DNA topoisomerases. Biochemistry 27:2253–2259
Blower TR, Williamson BH, Kerns RJ, Berger JM (2016) Crystal structure and stability of gyrase–fluoroquinolone cleaved complexes from Mycobacterium tuberculosis. Proc Natl Acad Sci USA 113:1706–1713
Aubry A, Pan X-S, Fisher LM, Jarlier V, Cambau E (2004) Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity. Antimicrob Agents Chemother 48:1281–1288
Matrat S, Aubry A, Mayer C, Jarlier V, Cambau E (2008) Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones. Antimicrob Agents Chemother 52:2909–2914
Skauge T, Turel I, Sletten E (2002) Interaction between ciprofloxacin and DNA mediated by Mg2+-ions. Inorg Chim Acta 339:239–247
CrystalClear (2005) Rigaku/MSC Inc., The Woodlands, Texas
Sheldrick GM (2008) A short history of SHELX. Acta Crystallogr A64:112–122
Sheldrick GM (2015) Crystal structure refinement with SHELXL. Acta Crystallogr C71:3–8
Pruzanski W, Saito S (1988) Comparative study of phagocytosis and intracellular bactericidal activity of human monocytes and polymorphonuclear cells. Application of fluorochrome and extracellular quenching technique. Inflammation 12:87–97
Miliotis MD (1991) Acridine orange stain for determining intracellular enteropathogens in HeLa cells. J Clin Microbiol 29:830–831
Matsushima T, Hayashi M, Matsuoka A, Jr M, Ishidate KF, Miura Y, Shimizu Y, Suzuki K, Morimoto H, Ogura K, Koshi K, Sofuni T (1999) Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis 14:569–580
Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E (2003) HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534:65–75
Muller K, Kasper P, Muller L (1993) An assessment of the in vitro hepatocyte micronucleus assay. Mutat Res 292:213–224
Kovalchuk I, Kovalchuk O, Arkhipov A, Hohn B (1998) Transgenic plants are sensitive bioindicators of nuclear pollution caused by the Chernobyl accident. Nat Biotechnol 16:1054–1059
Thomsen R, Christensen MH (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49:3315–3321
Krieger E, Vriend G (2015) New ways to boost molecular dynamics simulations. J Comput Chem 36:996–1007
Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C (2006) Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins 65:712–725
Krieger E, Nielsen JE, Spronk CAEM, Vriend G (2006) Fast empirical pKa prediction by Ewald summation. J Mol Graph Model 25:481–486
Acknowledgements
(1) This work was carried out in partial fulfillment of the requirements for an M.Sc. thesis of I.M. within the graduate program in Medicinal Chemistry under the supervision of SKH. (2) CNB and SKH would like to thank the Unit of Bioactivity Testing of Xenobiotics, of the University of Ioannina, for providing access to the facilities. (3) CNB and SKH would like to thank the Atherothrombosis Research Centre of the University of Ioannina for providing access to the fluorescence microscope. (4) The COST Action CA15114 “Anti-Microbial Coating Innovations to prevent infectious diseases (AMICI)” is acknowledged for the stimulating discussions. (5) Ciprofloxacin hydrochloric salt was purchased from Help Pharmaceutical which is acknowledged. HCET cells were kindly provided by Dr Maria Notara (Research Fellow, Dept. of Ophthalmology, University Hospital of Cologne, Germany) who is acknowledge. (6) The synthesis of CIPAG is protected by Greek patent No. 108941. The authors of this paper are included to the patent’s inventors.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Milionis, I., Banti, C.N., Sainis, I. et al. Silver ciprofloxacin (CIPAG): a successful combination of chemically modified antibiotic in inorganic–organic hybrid. J Biol Inorg Chem 23, 705–723 (2018). https://doi.org/10.1007/s00775-018-1561-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-018-1561-9